Evonik Corp. manufactures specialty chemicals. It manufactures coatings and advanced fillers, construction chemicals, fine & industrial chemicals, performance materials and specialty polymers. The company's products range from sports and industrial floorings to amino acids and building protection coatings. Evonik is headquartered in Parsippany, NJ.

Xi'an Libang Pharmaceutical Technology Co., Ltd., established on 1997-10-13, Business scope includes pharmaceutical,Pharmaceutical Intermediates,Fine Chemicals,Technology development of daily chemical products,technical consulting,Technical Services.

Sichuan Kelun Pharmacy Institute Co., Ltd., part of Sichuan Kelun Pharmaceutical Co., Ltd., is a company headquartered in Chengdu, China. The firm manufactures medicines. It was founded in 1998.

Changchun Yonggu Technology Co., Ltd., established on 2007-06-11, Business scope includes film,Conductive plastic,Research on insulating glue,to develop,Production,Sales;New material technology research and development;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the 3rd company of its kind ever created, and has a rich tradition of innovation and commercialization. Through our efforts to identify and create breakthrough scientific research at Hebrew University, we aspire to advance commercial solutions to the most pressing global challenges facing humanity. (Contact Tamir Huberman) Some of our well-known spin-off companies include Mobileye, Orcam, Collplant, Qlight, and Briefcam. Yissum’s business partners span the globe and include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.

Changchun Shengbomar Biomaterials Co., Ltd., established on 2007-04-19, The scope of business includes research on synthetic materials technology,to develop,technical consulting,Serve,technology transfer,synthetic material production,Sales(Excluding flammable, explosive and toxic chemical hazards);Class III6846Implantable materials and artificial organs,IIIkind6864Medical hygiene materials and dressings,IIkind6854operating room,emergency room,Consulting room equipment and appliances,IIkind6866Production of medical polymer materials and products(To operate during the validity period of the license);Iproduction of medical devices(The laws of the above business items,Items Prohibited by Regulations and State Council Decisions,Not allowed to operate;Licensed business projects operate with valid licenses or approval documents;General business items can choose to operate independently)*

Shenzhen Hybio Pharmaceutical Co., Ltd. (翰宇药业) is a high-tech enterprise which is engaged in research, development, production, and sales of polypeptide drugs. On the basis of strict production management and quality control according to the GMP strictly, it breaks through the bottle-neck of the polypeptide drugs' large-scale production technology by means of introduction digestion, independent innovation, and any other patterns. Shenzhen Hybio Pharmaceutical has successively applied for 38 patents, with 5 patents for invention, 7 national new drug certificates, 5 new drug clinical trial permissions, and 45 drug registration letters. The drugs are mainly used to treat diseases such as digestive diseases, cardiovascular and cerebrovascular diseases, diabetes, infectious diseases, tumors, senile diseases, and more.

Shanghai Modern Pharmaceutical Preparation Engineering Research Center Co., Ltd., established on 1996-06-10, Business scope includes general items:Chinese and Western medicine preparations,Health care pharmaceutical preparations,Technology development on the application technology of pharmaceutical excipients,technical consulting,Technical Services,technology transfer;Design of preparation equipment,analyze;Pharmaceutical Raw Materials,Research on Testing Technology of Packaging Materials;Sales of preparation equipment;Own house rental.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Inspection and testing service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Daegu Gyeongbuk Institute of Science and Technology (DGIST) (In Korean 대구경북과학기술원) is a public science and engineering university located in Daegu Metropolitan City, Republic of Korea. Under a Special Act on Support of Scientists and Engineers for Strengthening National Science and Technology Competitiveness, the Korean government enacted Daegu Gyeongbuk Institute of Science and Technology Act (Act No. 6996) and founded DGIST in 2004 as a research institute. In 2008, the act was amended to extend the role of the institute to both research and education, which eventually enabled a transition from a research institute to a university.

Pansheng Ruixiang (Shandong) Bioengineering Co., Ltd., established on 2018-07-24, Business scope includes general items:Manufacturing of daily chemical products;Manufacturing of medical packaging materials;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Disinfectant sales(Free of Hazardous Chemicals);Sales of hygiene products and single-use medical products;Cosmetics Retail;Cosmetics Wholesale;internet sales(Except for products that require a license for sale);R&D and application of cell technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Development of Human Gene Diagnosis and Therapy Technology.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Production of hygiene products and single-use medical products;Cosmetic production;Production of Class II Medical Devices;Production of Class III Medical Devices;Disinfectant production(Free of Hazardous Chemicals);Class III medical device business;The first type of value-added telecommunications services;The second type of value-added telecommunications services;Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

ICCAS was founded in 1956. ICCAS is a multi-disciplinary research institute dedicated to the basic research in broad fields of chemical sciences, and to the key developments of the innovative high technologies aiming to the imperative national needs and important strategic targets, as well as to the collaborative high-technology applications and transfers. ICCAS is one of China’s leading chemistry research institutions with high international reputation.

GCS Co., Ltd. is a South Korean company that manufactures and sells skincare medical devices.

Quantum University provides online courses and graduates degree programs in holistic, alternative, natural, and integrative medicine.

Anhui Guoxing Biochemicals Co. Ltd., part of Nanjing Red Sun Co., Ltd., is a company headquartered in Maanshan, China, that manufactures and distributes agricultural chemicals.

Nanjing Dongshang Biotechnology Co., Ltd., established on 2016-09-30, Business scope includes biological,medical technology development,technical consulting,Technical Services,technology transfer,Technical Training(Does not include training or services related to academic education);3D printing technology development,Sales;production of medicines,Sales;Medical Device Sales;automation equipment,Smart device research and development,Sales;Computer software and hardware technology research and development,Sales;Computer Information Technology Services;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts the company to operate or prohibits the import and export of).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Changchun High & New Technology Industries (Group), Inc., Changchun Genescience Pharmaceuticals Co., Ltd. is a Chinese company located in Changchun. The firm manufactures pharmaceuticals products. It was founded in 1997. Lei Jin is the current CEO of the firm.